LoginSignup
Lantheus Hldg logo

Lantheus Hldg

Stock
Stock
ISIN: US5165441032
Ticker: LNTH
US5165441032
LNTH

Price

Price

CHART BY

Frequently asked questions

What is Lantheus Hldg's market capitalization?

The market capitalization of Lantheus Hldg is $6.21B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Lantheus Hldg's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Lantheus Hldg is 14.84. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Lantheus Hldg?

Lantheus Hldg's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $6.018. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Lantheus Hldg's stock?

Currently, 13 analysts cover Lantheus Hldg's stock, with a consensus target price of $134.69. Analyst ratings provide insights into the stock's expected performance.

What is Lantheus Hldg's revenue over the trailing twelve months?

Over the trailing twelve months, Lantheus Hldg reported a revenue of $1.50B.

What is the EBITDA for Lantheus Hldg?

Lantheus Hldg's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $536.79M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Lantheus Hldg?

Lantheus Hldg has a free cash flow of $451.98M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Lantheus Hldg have, and what sector and industry does it belong to?

Lantheus Hldg employs approximately 834 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.

What is the free float of Lantheus Hldg's shares?

The free float of Lantheus Hldg is 67.79M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$6.21B
EPS (TTM) 
$6.018
Free Float 
67.79M
P/E ratio (TTM) 
14.84
Revenue (TTM) 
$1.50B
EBITDA (TTM) 
$536.79M
Free Cashflow (TTM) 
$451.98M

Pricing

1D span
$88.49$92.25
52W span
$50.24$126.54

Analyst Ratings

The price target is $134.69 and the stock is covered by 13 analysts.

Buy

12

Hold

1

Sell

0

Information

Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the U.S. and International geographical segments. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment offers direct distribution in Canada and third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific, Central America, and South America. The company was founded in 1956 and is headquartered in Bedford, MA.

Employees
834
Industries
Medical Specialties
Sector
Health Care

Identifier

ISIN
US5165441032
Primary Ticker
LNTH

Knockouts

Join the conversation
Sign upLogin